Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
Ester García-Pras, Anabel Fernández‐Iglesias, Jordi Gracia‐Sancho, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 48-48
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Elevated neutrophil extracellular traps by HBV‐mediated S100A9‐TLR4/RAGE‐ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma
Xi Zhan, Rui Wu, Xuehua Kong, et al.
Cancer Communications (2022) Vol. 43, Iss. 2, pp. 225-245
Open Access | Times Cited: 76
pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation
Zhouxiang Liao, Lichao Yang, Xiaojing Cheng, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma
Xi‐Fei Jiang, Wenjia Deng, Siyao Tao, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 31
SULT2B1-CS-DOCK2 axis regulates effector T-cell exhaustion in HCC microenvironment
Shuai Wang, Rui Wang, Nan Xu, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1064-1078
Closed Access | Times Cited: 25
Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification
Guoqing Ouyang, Qiuyun Li, Yangnian Wei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
Weijia Wang, Behishta Hashimi, Ping Wang
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1166-1166
Open Access | Times Cited: 21
Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects
Xiang’an Wu, Jingying Cao, Xueshuai Wan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Research progress in nano-drug delivery systems based on the characteristics of the liver cancer microenvironment
Shijia Lu, Chenxiao Zhang, Jinglong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116059-116059
Open Access | Times Cited: 15
Unveiling efferocytosis-related signatures through the integration of single-cell analysis and machine learning: a predictive framework for prognosis and immunotherapy response in hepatocellular carcinoma
Tao Liu, Chao Li, Jiantao Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review)
Honglian Yu, Qiang Bian, Xin Wang, et al.
Oncology Reports (2024) Vol. 51, Iss. 3
Open Access | Times Cited: 5
Novel pyroptosis-immune-related lncRNA signature exhibits a distinct immune cell infiltration landscape in breast cancer
Dedi Kong, Hongju Cheng, Meihong Wang
Frontiers in Immunology (2025) Vol. 15
Open Access
Machine learning and molecular subtyping reveal the impact of diverse patterns of cell death on the prognosis and treatment of hepatocellular carcinoma
Xinyue Yan, Meng Wang, L. Min Ji, et al.
Computational Biology and Chemistry (2025) Vol. 115, pp. 108360-108360
Closed Access
Role of oxeiptosis in disease mechanisms and therapeutic opportunities
K. Bhuvaneshwari, Kannan Harithpriya, Kumar Ganesan, et al.
APOPTOSIS (2025)
Closed Access
Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response
Yongguang Wei, Chenlu Lan, Chengkun Yang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment
Sara F. Awwad, Raymonde Assaf, Ahmed A. Emam, et al.
Medical Oncology (2023) Vol. 40, Iss. 3
Open Access | Times Cited: 9
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma
Anna Tutusaus, Marco Sanduzzi‐Zamparelli, Loreto Boix, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1491-1491
Open Access | Times Cited: 3
基于高分辨光声显微成像的肝癌微血管特征分析
孙彤 Sun Tong, 黄国家 Huang Guojia, 张振辉 Zhang Zhenhui
Chinese Journal of Lasers (2023) Vol. 50, Iss. 15, pp. 1507105-1507105
Open Access | Times Cited: 7
Laminaria japonica Peptides Suppress Liver Cancer by Inducing Apoptosis: Possible Signaling Pathways and Mechanism
Yingzi Wu, Yuanhui Li, Wenhai Guo, et al.
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 704-704
Open Access | Times Cited: 11
Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response
Yumei Ning, Kun Lin, Jun Fang, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-19
Open Access | Times Cited: 6
ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
Qiu Sun, Xudong Liu, Qunlong Peng, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 8
Inflammasome-Mediated Cytokines: A Key Connection between Obesity-Associated NASH and Liver Cancer Progression
Nathalia Soares da Cruz, Gabriel Pasquarelli-do-Nascimento, Augusto Cézar Polveiro e Oliveira, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2344-2344
Open Access | Times Cited: 8
Integrated multiomics analysis identified comprehensive crosstalk between diverse programmed cell death patterns and novel molecular subtypes in Hepatocellular Carcinoma
Li Chen, Yuanbo Hu, Yu Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
Kaihua Tang, Xiaoting Li, Jianwen Mo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma
Ke Xu, Yu Liu, Hui Luo, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top